Loading
Lymphoma specialist and Chief Executive Officer of the National Cancer Centre Singapore, the country's largest public cancer centre.
Lim Soon Thye is Chief Executive Officer of the National Cancer Centre Singapore (NCCS), part of the SingHealth cluster. A medical oncologist specialising in lymphoma, he has led research on T-cell and NK/T-cell lymphomas prevalent in Asian populations and co-founded regional lymphoma study groups. As CEO he oversees NCCS's clinical services, research divisions and education programmes.
| Title | Journal | Year |
|---|---|---|
| Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial | Blood | 2018 |
| Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group | Journal of Hematology & Oncology | 2020 |
| Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, and Post-transplant Lymphoproliferative Disorder | American Society of Clinical Oncology Educational Book | 2016 |
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
Shares Diffuse large B-cell lymphoma and the tags leadership, clinician-scientist, lymphoma.
Shares Journal of hematology & oncology and the tags leadership, clinician-scientist.